ArticleToxicology reports2026
Lycopene supplementation during pregnancy and lactation attenuates thermally oxidized cooking oil-induced hepatic and cerebral damage in rat offspring: A comprehensive histomorphometric and molecular analysis.
Article in Toxicology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Thermally oxidized cooking oil (TOCO) generates reactive oxygen species and lipid peroxidation products that cross the placental barrier, posing risks to offspring organ development in low-to-middle income countries where cooking oil reuse is endemic. Lycopene, a potent carotenoid antioxidant, possesses neuroprotective and hepatoprotective properties, yet its capacity to prevent maternal-to-offspring oxidative damage through maternal supplementation remains unexplored. Methods: Twenty-four female Sprague Dawley rats were randomized into six groups (n = 4 dams each): Control, CMC vehicle, TOCO1 × , TOCO3 × , TOCO1 × + Lycopene, and TOCO3 × + Lycopene. Lycopene (0.24 mg/kg) was administered via oral gavage from gestational day 1 through postnatal day 14 (total duration: 35 days encompassing pregnancy and early lactation). Dam was used as the experimental unit for all inferential statistics to avoid pseudo-replication. Statistical analysis employed Kruskal-Wallis and Mann-Whitney U tests with Benjamini-Hochberg FDR correction, effect size estimation (Cohen's d with 95% CI), and post-hoc power analysis. Results: TOCO3 × exposure significantly reduced normal hippocampal CA1 neurons (60% vs 85% controls; Cohen's d=2.2, p < 0.05), cerebellar Purkinje cells (55% vs 90%; d=2.5, p < 0.05), and increased hepatocyte damage (27% vs 8%; d=2.8, p < 0.05). Lycopene supplementation provided substantial protection: hippocampal recovery to 75% (PI 60%), cerebellar recovery to 78% (PI 66%), liver recovery to 15% damaged (PI 63%), with NNT of 4-5. Biochemical markers (MDA, GSH) showed non-significant trends (post-hoc power 15-42%). Caspase-3 expression showed dose-dependent elevation with TOCO and suppression with lycopene. Conclusions: Maternal lycopene supplementation provides significant multi-organ protection against TOCO-induced developmental toxicity. These findings are supported by convergent evidence from histopathology (d=2.2-2.8), molecular markers (caspase-3 dose-response), and exposure characterization, consistent with oxidative stress-mediated mechanisms. The translational HED (2.7 mg/day from 150 g fresh tomatoes) supports investigation of dietary lycopene as a public health intervention for pregnant women in TOCO-endemic populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.